252 related articles for article (PubMed ID: 6234252)
1. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
Yamamoto T; Yamashita T; Tsubura E
Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pulmonary metastasis by Nocardia rubra cell wall skeleton, with special reference to macrophage activation.
Kagawa K; Yamashita T; Tsubura E; Yamamura Y
Cancer Res; 1984 Feb; 44(2):665-70. PubMed ID: 6692370
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of cepharanthin--mechanism of the antimetastatic effect on Lewis lung carcinoma (3LL)].
Ono M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):249-55. PubMed ID: 3341787
[TBL] [Abstract][Full Text] [Related]
4. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).
Suzuki M; Arika T; Amemiya K; Fujiwara M
Jpn J Exp Med; 1982 Apr; 52(2):59-65. PubMed ID: 6214649
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung metastasis by a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), in mice bearing Lewis lung carcinoma.
Ito H; Wang JZ; Shimura K
Anticancer Res; 1991; 11(1):249-52. PubMed ID: 2018358
[TBL] [Abstract][Full Text] [Related]
6. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG).
Inomata T; Goodman GB; Fryer CJ; Chaplin DJ; Palcic B; Lam GK; Nishioka A; Ogawa Y
Br J Cancer Suppl; 1996 Jul; 27():S122-5. PubMed ID: 8763863
[TBL] [Abstract][Full Text] [Related]
7. Immunological analysis of inhibition of lung metastases by fucoidan (GIV-A) prepared from brown seaweed Sargassum thunbergii.
Itoh H; Noda H; Amano H; Ito H
Anticancer Res; 1995; 15(5B):1937-47. PubMed ID: 8572581
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
[TBL] [Abstract][Full Text] [Related]
9. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
10. Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975).
Desoize B; Carpentier Y; Guerrier D
Anticancer Res; 1989; 9(6):1701-5. PubMed ID: 2627123
[TBL] [Abstract][Full Text] [Related]
11. [Influence of interferon on the toxic effect and antitumor activity of vinblastine in the combined therapy of metastatic Lewis carcinoma].
Vorontsova AL; Kudriavets IuI; Fadeev VA
Eksp Onkol; 1984; 6(6):54-7. PubMed ID: 6084588
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of the host response to Lewis lung carcinoma: modulation by pyran.
Snodgrass MJ; Morahan PS; Kaplan AM
J Natl Cancer Inst; 1975 Aug; 55(2):455-62. PubMed ID: 1159827
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems.
Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1415-20. PubMed ID: 2142485
[TBL] [Abstract][Full Text] [Related]
15. Participation of macrophages in the mechanism mediating the enhancement of metastasis formation after tumour resection.
Yunker VM; Taraskina NP; Ustinov AS
Biomed Sci; 1991; 2(6):569-75. PubMed ID: 1841624
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
[TBL] [Abstract][Full Text] [Related]
17. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
19. Prevention of pulmonary metastasis of Lewis lung carcinoma and activation of murine macrophages by a novel organic germanium compound, PCAGeS.
Sato I; Nishimura T; Kakimoto N; Suzuki H; Tanaka N
J Biol Response Mod; 1988 Feb; 7(1):1-5. PubMed ID: 3373232
[TBL] [Abstract][Full Text] [Related]
20. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]